Related references
Note: Only part of the references are listed.The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features
Christopher J. Schwartz et al.
MODERN PATHOLOGY (2022)
Predictors of Outcome in Mammary Adenoid Cystic Carcinoma A Multi-Institutional Study
Elzbieta Slodkowska et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
Julie Masse et al.
MODERN PATHOLOGY (2020)
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
Mattias K. Andersson et al.
ONCOGENESIS (2020)
Treatment Patterns and Clinical Outcomes of Adenoid Cystic Breast Carcinoma: A Single-Institution Experience
Macy M. Goldbach et al.
AMERICAN SURGEON (2020)
MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH
Justin S. Poling et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
Young Kwang Chae et al.
ONCOTARGET (2015)
MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features
Timothy M. D'Alfonso et al.
HUMAN PATHOLOGY (2014)
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Scott A. Laurie et al.
LANCET ONCOLOGY (2011)
Solid variant of mammary adenoid cystic carcinoma with basaloid features - A study of nine cases
SJ Shin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Share Paper
